Turkish Journal of Pharmaceutical Sciences
Overview
Turkish Journal of Pharmaceutical Sciences is a scientific journal, published since 2004 in English. The journal's country of origin is Türkiye and its primary focus area is pharmacology.
Details
Details
Abbr.
Turk J Pharm Sci
Start
2004
End
Continuing
Frequency
Three times a year
p-ISSN
1304-530X
e-ISSN
2148-6247
Country
Türkiye
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 11956
22
SJR / Ranks: 10934
364
CiteScore / Ranks: 9809
2.40
Recent Articles
1.
Suttithumsatid W, Sukketsiri W, Panichayupakaranant P
Turk J Pharm Sci
. 2025 Mar;
22(1):64-70.
PMID: 40052396
Objectives: This study aimed to explore the use of D-limonene and some vegetable oils with different amounts of saturated and unsaturated fatty acids as alternative green solvents for microwave-assisted extraction...
2.
Cakmakyapan O, Tugcu Demiroz F, Teksin Z
Turk J Pharm Sci
. 2025 Mar;
22(1):55-63.
PMID: 40052381
Objectives: Orodispersible films (ODFs) are new-generation dosage forms that increase patient compliance, providing ease of drug administration in many patient groups, such as pediatric, geriatric, and patients with physiological and...
3.
Sonule B, Khairnar Y, Mehetre N, Kumar S, Kumar L
Turk J Pharm Sci
. 2025 Mar;
22(1):46-54.
PMID: 40052380
Objectives: This study aimed to formulate and evaluate etoricoxib suppositories to improve patient compliance and drug efficacy in the management of hemorrhoids. Materials And Methods: Suppositories were prepared using glycerin...
4.
Ozkaya Y, Ozcelikay G
Turk J Pharm Sci
. 2025 Mar;
22(1):38-45.
PMID: 40052379
Objectives: This study aimed to explore the relationship between emotional labor, professional commitment, and self-efficacy among community pharmacists. Specifically, this study examined how self-efficacy influences professional commitment and the mediating...
5.
Kasim H, Salih A, Al Hamdany H
Turk J Pharm Sci
. 2025 Mar;
22(1):26-37.
PMID: 40052361
Objectives: Informing patients about the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) is essential to ensure their safe use. The aim of this study was to determine whether the years...
6.
Kotte S, Nagendra V, Vishwanathan B, Sivasankaran P
Turk J Pharm Sci
. 2025 Mar;
22(1):19-25.
PMID: 40052339
Objectives: Treatment outcomes for patients with arrhythmias, deep vein thrombosis, prosthetic valves, blood thinning, and cardiac issues/chest pain problems can be affected by knowledge about oral anticoagulant therapy. The primary...
7.
Elci M, Fatsa T, Oren S, Miser Salihoglu E, Akaydin S
Turk J Pharm Sci
. 2025 Mar;
22(1):10-18.
PMID: 40052338
Objectives: Neuroblastoma, an embryonic tumor of the sympathetic nervous system, is the deadliest type of cancer, accounting for 6-9% of all childhood cancers. The omega (ω)-6 [linoleic acid (LA)]: ω-3...
8.
Tarikogullari Dogan A, Saylam M, Yilmaz S, Parlar S, Ballar P, Alptuzun V
Turk J Pharm Sci
. 2025 Mar;
22(1):1-9.
PMID: 40052327
Objectives: Excessive amounts of neuroapoptosis are the underlying cause of neurodegenerative diseases. Bax is a pro-apoptotic member of the B-cell lymphoma-2 family that activates caspases which are the members of...
9.
Rahimi M, Ramezani M, Shadnia S, Mostafazadeh B, Azandaryani M, Alijanzadeh M, et al.
Turk J Pharm Sci
. 2025 Jan;
21(6):577-581.
PMID: 39801110
Objectives: Constipation caused by opioid-induced constipation (OIC) is prevalent among critically poisoned patients and can result in complications that prolong hospitalization and, in rare cases, cause bowel perforatio This research...
10.
Hamdan M, Kulabas N, Kucukguzel I
Turk J Pharm Sci
. 2025 Jan;
21(6):566-576.
PMID: 39801109
Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), from the family Coronaviridae, is the seventh known coronavirus to infect humans and cause acute respiratory syndrome. Although vaccination efforts have been...